News
Read our latest SpOTLight newsletter for a digest of OTL news:
-
SPOTLIGHT December 2023 - Holiday Edition!
Featured: InvinciKids & the Stanford Chariot Program deliver virtual reality alternatives for pediatric anesthesiology
December 15, 2023
Read additional news about OTL, our licensees, and Stanford technologies:
-
Stanford Startup Synthekine Announces U.S. FDA Clearance of IND Application for CD19 CAR-T and Orthogonal IL-2 Combination Therapy, SYNCAR-001 + STK-009, for Treatment of Lupus Without Lymphodepletion
SYNCAR-001 + STK-009 combination will be studied in two distinct lupus patient populations: non-renal systemic lupus erythematosus (SLE) and lupus nephritis (LN)
March 26, 2024
-
BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
BridgeBio merged with Stanford Startup Eidos Therapeutics in 2021
March 04, 2024
-
Stanford Startup Synthekine Announces Strategic Collaboration with Sanofi
They've entered into worldwide collaboration with Sanofi to develop and commercialize IL-10 receptor agonists for the treatment of inflammatory diseases.
January 29, 2024
-
SPOTLIGHT December 2023 - Holiday Edition!
Featured: InvinciKids & the Stanford Chariot Program deliver virtual reality alternatives for pediatric anesthesiology
December 15, 2023
-
December 15, 2023
-
December 11, 2023
-
SPOTLIGHT October 2023
Featured: Discussing the Promise and Future of RNA Medicines with Dr. Howard Chang
October 12, 2023
-
October 12, 2023
-
October 12, 2023
-
October 12, 2023
-
March 01, 2023
-
Stanford University and The Invus Group collaborate to develop glioblastoma drugs
The collaboration will enable the development of medications to treat a type of brain cancer.
January 09, 2023
-
SPOTLIGHT December 2022
Stanford’s Carolyn Bertozzi wins Nobel in chemistry
December 15, 2022
-
December 15, 2022
-
SPOTLIGHT September 2022
Inventor Spotlight: Prof. Crystal Mackall speaks with OTL about the promise of cell therapy in pediatric diseases
October 06, 2022
-
Magnus Medical Receives FDA Clearance for the SAINT Neuromodulation System for Non-Invasive, Individualized and Precise Treatment of Severe Depression
Magnus Medical Receives FDA Clearance for the SAINT Neuromodulation System for Non-Invasive, Individualized and Precise Treatment of Severe Depression
September 22, 2022
-
Unlocking Cell Therapy in Pediatric Diseases: A Conversation with Crystal Mackall
In a conversation with OTL, Dr. Crystal Mackall highlights the most challenging and fulfilling parts of her work.
September 13, 2022
-
Sowing Seeds for the Future: OTL's Inaugural Internship Program
OTL’s internship program, kicked off in early March 2020, provides a training ground for entrepreneurial-minded post-docs and grad students.
March 17, 2022
-
SPOTLIGHT March 2022
Sowing Seeds for the Future: OTL's Inaugural Internship Program
March 01, 2022
-
Deerfield and Stanford University Create the Porter Alliance for Innovative Medicines
Deerfield Management Commits up to $130 Million to Support Stanford’s Innovative Translational Research
January 18, 2022